purinergic P1 receptor agonists

Preferred Label : purinergic P1 receptor agonists;

MeSH definition : Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS.;

MeSH synonym : P1 purinoceptor agonists; agonists, P1 purinoceptor; purinoceptor agonists, P1; adenosine receptor agonists; agonists, adenosine receptor; receptor agonists, adenosine;

Is substance : O;

action pharmacologique : O;

Détails

Origin ID

D058906;

UMLS CUI

C2917322;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
MeSH Descriptor(s) used for indexing
- receptors, purinergic p1 [MeSH Descriptor]
Record concept(s)
- purinergic P1 receptor agonists [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 2-((1-phenylpropyl)amino)adenosine [MeSH Supplementary Concept]
- 2-((phenylisopropyl)amino)adenosine [MeSH Supplementary Concept]
- 2-(2-phenylethoxy)adenosine [MeSH Supplementary Concept]
- 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)-5'-N-ethylcarboxamidoadenosine [MeSH Supplementary Concept]
- 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide [MeSH Supplementary Concept]
- 2-hexyloxyadenosine [MeSH Supplementary Concept]
- 5'-O-ethyl-N-(3-iodobenzyl)adenosine [MeSH Supplementary Concept]
- 8-butylamino-N(6)-cyclopentyladenosine [MeSH Supplementary Concept]
- 8-butylaminoadenosine [MeSH Supplementary Concept]
- CVT 2759 [MeSH Supplementary Concept]
- KMCP 98 [MeSH Supplementary Concept]
- N(6)-(4-sulfophenyl)adenosine [MeSH Supplementary Concept]
- N(6)-benzyl-5'-N-ethylcarboxamidoadenosine [MeSH Supplementary Concept]
- N(6)-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine [MeSH Supplementary Concept]
- N(6)-cyclopentyladenosine [MeSH Supplementary Concept]
- N-((1S,trans)-2-hydroxycyclopentyl)adenosine [MeSH Supplementary Concept]
- N-(3-iodobenzyl)-5'-O-methyladenosine [MeSH Supplementary Concept]
- N6-(4-(((4-((((2-((((isothiocyanatophenyl)amino)thiocarbonyl)amino)ethyl)amino)carbonyl)methyl)anilino)carbonyl)methyl)phenyl)adenosine [MeSH Supplementary Concept]
- RS 74513-000 [MeSH Supplementary Concept]
- VUF 5455 [MeSH Supplementary Concept]
- adenosine [MeSH Descriptor]
- binodenoson [MeSH Supplementary Concept]
- ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate [MeSH Supplementary Concept]
- tecadenoson [MeSH Supplementary Concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients